Particulate matter cytotoxicity in cultured SH-SY5Y cells is modulated by simvastatin: Toxicological assessment for oxidative damage by Ferraro, Sebastián Ariel et al.
Accepted Manuscript
Title: Particulate matter cytotoxicity in cultured SH-SY5Y
cells is modulated by Simvastatin: toxicological assessment
for oxidative damage








Please cite this article as: Ferraro SA, Astort F, Yakisich JS, Tasat
D.R.Particulate matter cytotoxicity in cultured SH-SY5Y cells is modulated
by Simvastatin: toxicological assessment for oxidative damage.Neurotoxicology
http://dx.doi.org/10.1016/j.neuro.2016.01.003
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1 
 
Particulate matter cytotoxicity in cultured SH-SY5Y cells is modulated by Simvastatin: 




Ferraro SA1, Astort F1, Yakisich JS2, Tasat DR 1,3 
 
1 Center of Studies in Health and Environment, School of Science and Technology, National 
University of San Martín, San Martín, Buenos Aires, Argentina. 
 
2 Department of Pharmaceutical Science, Hampton University, VA, USA.  
 
3 Department of Histology and Embryology, School of Dentistry, University of Buenos Aires, 




Sebastián Ariel Ferraro 
School of Science and Technology,  
National University of General San Martín, 
Martín de Irigoyen 3100 (1653) San Martín, 
Buenos Aires, Argentina. 
Telephone #: (5411) 45807296 






















 There’s a correlation between environmental particulate matter and health effects.  
 We studied in vitro simvastatin’s potential protective effect on ROFA cytotoxicity.  
 ROFA decreased cell viability, increased ROS generation, apoptosis and senescence.  
 Pretreatment with simvastatin attenuated the adverse effects observed.  
























Epidemiological studies have shown a positive correlation between environmental 
particulate matter and adverse health effects. In particular, Residual Oil Fly Ash (ROFA) 
induces inflammation and reactive oxygen species (ROS), exerting not only local, but also 
systemic adverse effects. Previously, in an experimental animal model, we found that 
Simvastatin (Sv) pretreatment was effective in preventing ROFA induced lung inflammation. 
Herein, using the human neuroblastoma SH-SY5Y cell line as a neurotoxicity in vitro model, 
we studied the potential Sv protective effect on ROFA cytotoxicity. We evaluated cell viability 
by the MTT assay, superoxide anion generation by NBT test, Nrf2 activation by 
immunofluorescence, apoptosis by cleaved-PARP and active-caspase 3 expressions, and 
senescence by β–galactosidase activity. SH-SY5Y cells exposed to ROFA (10 and 50 µg/ml) 
for 24 hs showed decreased cell viability, increased superoxide anion generation, apoptosis 
and senescence. Pretreatment with Sv (1 µM) for 6 days, restored cell viability to basal levels, 
reduced ROFA-induced O2- generation as well as the number of apoptotic and senescent 
cells. Sv pre-treatment stimulated the basal and ROFA-induced levels of Nrf2 nuclear 
translocation suggesting that activation of the cellular antioxidant defense system prevented 
particle-induced oxidative stress.  In parallel, rescue experiments with mevalonate did not 
modify the effects of SV pretreatment in any of the parameters evaluated in this study.  We 
conclude that simvastatin may provide neuroprotection against air particulate matter-induced 
neurotoxicity independently of its ability to inhibit cholesterol synthesis.  
 
















Epidemiological studies have shown a positive correlation between decreased air quality 
levels and adverse health effects (Brunekreef and Holgate, 2002). Anthropogenic emissions 
are the main contributors to environmental particulate matter (PM) burden and consist mainly 
of motor vehicle emissions and fossil fuel combustion during power generation and industrial 
processes (Nel, 2005). Among this last category, Residual Oil Fly Ash (ROFA) results from 
an incomplete combustion of carbonaceous materials and significantly contribute to ambient 
air PM burden (Costa and Dreher, 1997). In fact, inhaled or instilled ROFA induces in vivo a 
typical inflammatory response in the respiratory tract defined by the recruitment of 
polymorphonuclear cells (mainly neutrophils) into the lung parenchyma, a rise in the mucin 
PAS-positive cells of the respiratory epithelium and the release of proinflammatory cytokines 
like IL-1, IL-6, IL-8 and TNFα (Antonini et al., 2004; Costa et al., 2006). Moreover, ROFA not 
only exerts an inflammatory response but, an imbalance on the oxidative metabolism due to 
its high transition metal content (namely iron, nickel and vanadium) through the generation of 
reactive oxygen species (ROS) (Ghio et al., 2002).   
In normal cells, ROS are produced in a controlled manner regulating different cell processes 
(cell division, inflammation, immune function, autophagy, and stress response). Upon ROS 
generation, cytoplasmic Nrf2 is released from its inhibitor Keap-1, translocates into the 
nucleus, and forms a cofactor complex that binds to specific antioxidant responsive elements 
(ARE) found in promoters of phase II antioxidant and detoxifying enzymes (Kensler et al., 
2007). On the contrary, uncontrolled production of ROS, consequence of xenobiotics like 
PM, results in oxidative stress that if not counterbalanced by the antioxidant defense system 
to maintain the redox homeostasis in the cell, impairs cellular functions and may lead to 
cytotoxicity and cell death (Ma, 2013).  
Strong scientific evidence supports that the deposition of small particles in the lung 
provokes not only local, but also systemic adverse effects, when translocate from the lung to 
the systemic circulation (Brook and Rajagopalan, 2009; Kampfrath et al., 2011; Ying et al., 
2009). In particular, the neuropathological effects of PM were first described in mongrel dogs 
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where chronic brain inflammation and an acceleration of Alzheimer's disease-like pathology 
were evidenced by histology, suggesting that the brain is also adversely affected by air 
pollutants (Calderón-Garcidueñas et al., 2002; Calderón-Garcidueñas et al., 2003). Later, it 
was found that air pollution in humans is associated to cerebral hemodynamics and 
dangerous effects on structural brain aging, even in dementia and stroke-free individuals 
(Wellenius et al., 2013; Wilker et al., 2015).  
On the other hand, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors 
(statins) that are the most effective treatment for hypercholesterolemia and management of 
coronary heart disease (Law et al., 2003; Tobert, 2003) are, albeit with some controversies, 
used in the treatment of neurodegenerative diseases or conditions such as cerebrovascular 
disease (Goldstein et al., 2008; Nassief and Marsh, 2008), Alzheimer disease (Eckert et al., 
2005) and Parkinson’s disease (Friedman et al., 2013; Lee et al., 2013; Wahner et al., 2008) 
among other illnesses. The underlying molecular mechanisms of the beneficial effects of 
statins for these diseases are poorly understood and probably independent of their ability to 
inhibit the HMG-CoA reductase.  
We have previously shown that Simvastatin (Sv) pretreatment in both ROFA and in 
Urban Air Particles from Buenos Aires (UAP-BA) exposed animals, reduced lung oxidative 
stress and inflammation, therefore exerting a protective effect against environmental pollution 
(Ferraro et al., 2011).  
Simvastatin, among other statins, due to its characteristics which includes the ability 
to cross the blood brain barrier is considered the most appropriate to prevent 
neurodegenerative conditions (Sierra et al., 2011). In this context, we sought to elucidate the 
in vitro effect of Sv on human neuroblastoma SH-SY5Y cell line exposed to ROFA, 







Materials and Methods 
 
Ambient Air Particle Suspension  
Residual Oil Fly Ash (ROFA) particles were collected from Boston Edison Co., Mystic 
Power Plant (Everett, MA, US) and were kindly provided by Dr. J. Godleski (Harvard School 
of Public Health, MA, US). ROFA samples from this source have been previously 
characterized in terms of elemental composition and particle size (Killingsworth et al., 1997; 
Ferraro et al., 2011). Vanadium, nickel and iron are the predominant metals present as 
water-soluble sulfates, and particle mean aerodynamic diameter is 2.06±1.57 μm. PM 
samples were freshly prepared by suspending ROFA particles in sterile saline solution (0.5 
mg/ml), followed by 10 min incubation in an ultrasonic water bath before use. 
 
Human Neuroblastoma SH-SY5Y Cell Culture and Simvastatin or Mevalonate Pre-
Treatment  
SH-SY5Y human neuroblastoma cells were purchased from American Type Culture 
Collection (ATCC®, Manassas, VA). Cells were plated in 75-cm2 tissue culture flasks (BD 
Falcon, San Jose, CA) and grown in a 1:1 mixture of EMEM (Invitrogen Corp., Carlsbad 
CA) and F-12 Nutrient Mixture (SIGMA-Aldrich, St. Louis, MO) supplemented with 10% FBS 
and 1% penicillin–streptomycin (100 I.U./ml penicillin and 100 µg/ml streptomycin) (Gibco, 
Grand Island, NY). Neuroblastoma cells were maintained in 5% CO2 at 37ºC. For all 
experiments cells were plated initially at a density of 160,000 cells/ml.  
Neuroblastoma cells in culture were treated during 6 days with 1 µM Simvastatin (Sv) 
(Sigma-Aldrich, Cat #S6196, St. Louis, MO) and/or 1 mM Mevalonate (Mv) (Sigma-Aldrich, 
Cat #41288, St. Louis, MO).  
Stock solutions of Simvastatin (Sv, 0.1 M) and Mevalonate (Mv, 1M) were prepared in 
ethanol:NaOH  (95%)  and phosphate buffer saline (PBS, pH = 7.2) respectively, and stored 
in aliquots at -20ºC until use. Sv concentrations were performed in supplemented media as 
previously described (Butterick et al., 2010; Johnson-Anuna et al., 2007). Medium was 
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changed every other day during the growth and treatment phases, and both Sv and Mv were 
added fresh to the media during each medium change.  
 
Ambient Air Particle Protocol Exposure 
SH-SY5Y cells were cultured in 24 well plates in the presence or absence of Sv, or 
Sv + Mv and then exposed to ROFA (5, 10 or 50 μg/ml) for 24 hs. After exposure, cell 
cultures were assayed for cell viability, superoxide anion generation, apoptosis and 
senescence. It is worth to note that in order to ensure a uniform distribution, ROFA particles 
were sonicated for 10 min before use.  
 
Cell Viability: MTT Assay 
Cell viability was determined by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) (Sigma-Aldrich, Cat #M5655) assay, as described elsewhere 
(Molinari et al., 2003; Morgan, 1998). This assay is based on the conversion of MTT to 
formazan crystals by mitochondrial dehydrogenases of living cells. Briefly, media from 
controls or exposed to ROFA particles were removed, cell cultures were washed twice with 
PBS 1X, and 0.5 ml fresh complete growth medium supplemented with 50 μl MTT (4 mg/ml 
in PBS) was added for 3 hs. Immediately after incubation, 250 μl/well of SDS (10%) was 
added to stop the MTT reaction and solubilize the formazan precipitate. The optical density 
(OD) of the final solution was measured 24 hs later spectrophotometrically at 570 nm 
(Shimadzu UV-1201V).  
Superoxide Anion Generation: NBT Assay 
Superoxide anion (O2-) was evaluated on SH-SY5Y cultures by the Nitro Blue 
Tetrazolium (NBT) assay (Sigma-Aldrich, Cat #N6876) according to Segal AW (Segal, 1974). 
Briefly, 1ml NBT (0.1% in PBS) was added to each well and incubated for 45 min at 37ºC. 
After incubation, paraformaldehyde (0.4%) was added to stop the reaction and fix the cells. 
The presence of a blue formazan precipitate was indicative of reactive cells. At least 200 
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cells (reactive and non reactive) were counted by light microscopy (Nikon Alphaphot-2 V52) 
as described elsewhere (Molinari et al., 2000). Results are expressed as the percentage of 
reactive cells. 
Cellular senescence:  β–galactosidase assay 
Senescent SH-SY5Y cells were histochemically detected by the Senescence β–
galactosidase Staining kit (Cat # 9860, Cell Signaling Technology, Danvers, MA) following 
manufacturer’s instruction. At least 200 cells per well were counted by light microscopy 
(Nikon Alphaphot-2 V52). Results are expressed as the percentage of positive stained cells.  
 
Caspase-3 activity, PARP and Nrf2 Immunocytochemical Determination 
Caspase-3 and Poly ADP ribose polymerase (PARP) were determined using Anti-
Active Caspase-3 pAB (Promega, Cat.Nº: G748, Madison, WI) and Anti-PARP p85 Fragment 
pAB (Promega, Cat.Nº: G7341) antibodies. Nrf2 transcription factor was assayed using anti-
Nrf2 (Santa Cruz Biotechnology, Cat.Nº: sc-722, Dallas, TX). Briefly, cells were fixed with 
paraformaldehyde (4%) and permeabilized with Triton X-100 (0.2%). The fixed cells were 
blocked with Bovine Serum Albumin (BSA) (1%), and incubated with the primary antibody for 
Caspase-3 (1:500), PARP (1:250), or Nuclear factor erythroid 2-related factor 2 (Nrf2) 
(1:250) diluted in BSA (1%) during 18 hs. Cells were washed with PBS and incubated with 
secondary antibody conjugated with Cy-3 (1:100) for 1 hs. In order to identify cell nuclei, SH-
SY5Y cells were counterstained with 100 nM DAPI (Sigma-Aldrich, Cat #D9542, St. Louis, 
MO) for 5 min. Cells were observed under a Nikon TE300 fluorescence microscope (λem = 
615 nm for Cy3 and λem = 460 nm for DAPI). Results are expressed as the percentage of 
positive stained cells for Caspase 3, PARP or nuclear Nrf2.  
 
Statistical analysis 
All endpoints were run in triplicates for each experimental condition. One-way ANOVA 
with Newman-Keuls multiple comparisons post test was performed using GraphPad Prism 
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version 5.04 for Windows (GraphPad Software, San Diego California USA, 
www.graphpad.com). 
Results   
Simvastatin prevents viability decrease on ROFA exposed SH-SY5Y cells 
To determine if ROFA was toxic on SH-SY5Y cultures, cells were exposed to ROFA 
(5, 10 and 50 µg/ml) for 24 hs. At the lowest concentration employed, no changes were 
observed on cell viability using the MTT assay whereas, a significant (p<0.001) reduction on 
cell viability occurred in response to both 10 and 50 µg/ml of ROFA, suggesting a dose 
dependent toxicity in this neuroblastoma cell line (Figure 1).  
We also evaluated the ability of simvastatin (Sv)  to attenuate the toxic effect of ROFA on 
SH-SY5Y cells. Cells were pre-treated with Sv (1 µM) for 6 days and then exposed to ROFA 
(5, 10 and 50 µg/ml) for 24 hs as described under Materials and Methods. Sv pre-treatment 
attenuated ROFA toxic effects restoring cell viabiliy to basal levels (Figure 1). This effect was 
independent of its ability to inhibit HMG-CoA, since co-incubation with mevalonate (Mv) (by 
product of HMG-CoA reductase) did not modify Sv protective effect (Figure 1).  
In order to assay whether cell viability is modified by  Sv or Mv pre-treatment,  SH-
SY5Y cells were incubated with Sv: 0.1, 1 and 10 µM or Mv: 0.1, 1 and 2 mM for 6 days. 
Neither Sv nor Mv altered SH-SY5Y viability, evaluated by MTT assay, at the concentrations 
doses employed   (C = 0.719±0.033; Sv0.1 = 0.670±0.011; Sv1 = 0.651±0.005; Sv10 = 
0.668±0.011; Mv0.1 = 0.701±0.004; Mv1 = 0.682±0.016; Mv2 = 0.672±0.017).  
 
Simvastatin attenuates ROFA adverse effect on superoxide anion generation 
Based on the known oxidative stress-inducing properties of PM, we evaluated the 
generation of superoxide anion (O2-) on SH-SY5Y cell cultures exposed to ROFA (5, 10 and 
50 µg/ml) for 24 hs. Microphotographs of exposed and non-exposed neuroblastoma cells are 
shown in Figure 2A. Most cells from control cultures were colorless non-reactive while, 
ROFA exposed cells exhibited dark blue granules as a result of formazan precipitation. A 
dose-dependent response was observed after exposure to ROFA where a large proportion of 
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cells (60-70%) exposed to 10 and 50 µg/ml ROFA particles and even the lowest studied 
concentration (5 µg/ml) significantly increased the percentage of reactive positive cells as 
compared to untreated controls (p<0.001) (Figure 2B).  
Sv pre-treatment reduced O2- generation being its effect more evident for ROFA 10 
and 50 µg/ml (Figure 2B).  Sv alone induced a slight but not significant increase in the levels 
of O2- compared to control values. Again as for cell viability, in all ROFA exposed cell 
cultures, Sv+Mv co-treatment showed no significant changes on this cellular parameter with 
respect to Sv alone (C = 13.92±1.59%; Sv+Mv = 12.18±0.62%; Sv+ROFA5+Mv = 
17.12±2.21%; Sv+ROFA10+Mv = 29.40±0.51%; Sv+ROFA50+Mv = 34.17±1.54%) .   
 
Simvastatin enhances ROFA-induced antioxidant nuclear factor Nrf2 activation  
The nuclear factor erythroid 2-related factor (Nrf2) is a transcription factor that 
controls the redox homeostatic gene regulatory network. In response to both endogenous 
and exogenous stresses caused by ROS, Nrf2 translocates to the cell nuclei enhancing the 
expression of a multitude of antioxidant and phase II enzymes that restore redox 
homeostasis.  
To investigate the potential involvement of Nrf2, in the protective effect of Sv we 
evaluated Nrf2 nuclear translocation immunocytochemically. Figure 3A shows representative 
images of Nrf2 negative cell nuclei (Nrf2-) and Nrf2 positive cell nuclei (Nrf2+) indicative of 
Nrf2 nuclear translocation. SH-SY5Y cells exposed to ROFA showed an evident and 
significant dose-dependent Nrf2 nuclear translocation (Figure 3B).  
It is noteworthy that Sv pretreatment per se modulates Nrf2 nuclear translocation since there 
was a marked increase in Nrf2+ cell nuclei immunostaining when compared non Sv 
pretreated control cells. Furthermore, the combination of Sv and 5 or 10 µg/ml ROFA 
dramatically increased the percentage of Nrf2+ cell nuclei as compared to ROFA alone (p< 
0.001) (Figure 3B). On the contrary, cultured human neuroblastoma cells treated with a 
combination of Sv and the higher ROFA dose (50 µg/ml) showed a modest but still significant 
synergistic effect (p< 0.001) in comparison with non-Sv pretreated ROFA50 cells. 
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Cell cultures co-treated with Sv+Mv showed no significant changes when compared 
to Sv alone (C = 13.81±1.15%; Sv+Mv = 46.86±3.44%; Sv+ROFA5+Mv = 66.94±1.69%; 
Sv+ROFA10+Mv = 85.02±4.83%; Sv+ROFA50+Mv = 60.04±2.16%).   
 
Simvastatin diminishes apoptotic cell death induced by ROFA 
As described above, ROFA at concentrations ranging from 5 to 50 µg/ml after 24 hs 
induced a marked reduction in SH-SY5Y cell viability therefore, we sought to investigate cell 
death assessing apoptotic biomarkers (active caspase-3 and cleaved PARP) by a 
fluorescent immunocytochemical staining method.   
Exposure to increasing concentrations of ROFA (5, 10, 50 µg/ml) induced a dose-
dependent increment in apoptosis (Figure 4). Incubation with ROFA50, the higher 
concentration used, resulted in 8.2 or 4.6-fold increase percentage of the positive cells for 
active caspase-3 (p< 0.001, Figure 4A) or cleaved PARP (p< 0.001, Figure 4B) over control 
values, respectively.   
Sv pre-treatment was able to significantly diminish the percentage of apoptotic cells 
throughout the whole range of ROFA doses studied. As an example, the percentage of 
apoptotic cells evaluated either with active caspase-3 or cleaved PARP for Sv pretreated and 
exposed to ROFA50, in comparison to non Sv pretreated cells, fell 2.4 or 1.8 fold respectively. 
Again, Sv+Mv co-treatment showed no significant changes on cell death 
immunocytochemically evaluated with respect to Sv alone (Caspase-3: C = 6.79±0.71%; 
Sv+Mv = 7.21±1.76%; Sv+ROFA5+Mv = 11.24±1.28%; Sv+ROFA10+Mv = 17.08±0.79%; 
Sv+ROFA50+Mv = 22.79±1.68%; and PARP: C = 10.09±1.69%; Sv+Mv =7.69±1.02%; 
Sv+ROFA5+Mv = 11.51±1.43%; Sv+ROFA10+Mv = 20.06±1.35%; Sv+ROFA50+Mv = 
24.08±1.71%) . 
 
Simvastatin reduces ROFA-induced senescence in SH-SY5Y cells 
Senescence invokes a specific cell cycle profile that differs from most damage-
induced arrest processes and is characterized by an enlarged cell size, expression of pH-
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dependent beta-galactosidase activity and an altered pattern of gene expression. In our 
study, senescence was evaluated by senescence-associated β-galactosidase staining in 
control and exposed to ROFA (50 µg/ml) SH-SY5Y cells. Microphotographs show no reactive 
cells were observed in control cultures, while ROFA exposed cells showed reactivity as 
evidenced by the intense blue color (Figure 5A).  
ROFA particles provoked a dose dependent increase in the percentage of senescent 
cells. On the contrary, pretreatment with Sv significantly reduced this cellular process in 
cultures exposed to 10 and 50 µg/ml (Figure 5B). SH-SY5Y cultures treated with both Sv+Mv 
showed no variations in comparison to Sv alone (C = 4.72±1.58%; Sv+Mv =8.16±2.16%; 




Several reports have confirmed that the brain is a critical target of PM exposure 
implicating oxidative stress as a predisposing factor that links PM exposure and neurotoxic 
susceptibility (MohanKumar et al., 2008; Wilker et al., 2015). However, the underlying 
mechanisms and sequence of events that culminates in PM neurotoxicity remain poorly 
understood. In this context, we explored in vitro, the potential harmful effects of ROFA - a 
known ambient air particle pollutant - on SH-SY5Y, a human neuroblastoma cell line. 
As it was shown by our group and others, ROFA is a PM rich in soluble transition 
metals and low concentration of organic compounds (Ferraro et al., 2011; Schroeder et al., 
1987). Hence, ROFA is the most frequent combustion-derived particle used to evaluate the 
contribution of metallic traces on air pollution toxicity (Chen and Lippmann, 2009). In 
particular, it has been demonstrated that direct oxidant production from transition metals 
coated on ROFA surface may in turn, initiate oxidative imbalance (Carvalho et al., 2014; 
Ferraro et al., 2011). 
In the presence of environmental stressors like PM, reactive oxygen species (ROS) 
play an important role in cell signaling of many physiological and pathophysiological 
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processes. The results obtained in this study indicate that in vitro exposure of SH-SY5Y cells 
to ROFA particles in doses ranging from 10 to 50 μg/ml significantly compromise cell viability 
and augments superoxide anion generation. Superoxide anion (O2-), one of the main ROS, 
can oxidize and hence damage lipids, proteins and DNA which in turn may lead to different 
cell death processes (Lushchak, V.I, 2014; Rahal, A. et al., 2014). Two specific forms of cell 
death have received increased attention regarding PM exposure (Kanduc et al., 2002), being 
apoptosis the first of these processes and necrosis the second one. Nonetheless, in 
response to different kinds of stress, mammal cells can also develop a proliferative arrest 
known as “cell senescence” (Chen et al., 2005). Senescent cells are able to induce 
neighboring cells towards this process through soluble factors known as SASP (senescence 
associated secretory phenotype). It has been documented that both apoptosis and 
senescence are interconnected and interconvertible cellular processes (Childs et al., 2014). 
Interestingly, in this study, we have shown that ROFA particles in neuroblastoma cell not only 
induced apoptosis (Figure 4) but also senescence (Figure 5).  
Nrf2 regulates the basal and induced expression of an array of antioxidant response 
element (ARE) dependent genes to regulate the physiological outcomes of oxidant exposure 
(Montes et al., 2015).  In our study, ROFA exposed SH-SY5Y cells showed a dose 
dependent Nrf2 activation, which could be a consequence of a redox imbalance probably 
caused by the O2- augmentation.  
Chartoumpekis D et al., have shown that Sv lowers ROS by activating Nrf2 through 
the PI3K/Akt pathway (Chartoumpekis et al., 2010). In accordance, the rise of Nrf2 nuclear 
translocation in Sv pretreated SH-SY5Y cultures, suggests that in part, the protective effect 
observed may be mediated by an induction of the antioxidant defenses able to balance the 
production of O2- caused by ROFA exposure. Moreover, the rise in Nrf2 nuclear translocation 
was significantly higher in the Sv pretreated group, indicating that Sv per se was able to 
prime the cellular antioxidant defense system and counter particle - induced oxidative stress 
more efficiently. It is important to point out that, even though the immunostaining for Nrf2 is a 
useful method to detect the nuclear localization of Nrf2, the percentage of positive cells could 
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be misestimated. Therefore, another measurements of Nrf2 pathway activation in order to 
supplement and improve the results, as the assessment of nuclear Nrf2 protein levels by 
immunoblotting using nuclear protein extracts or the levels of Nrf2 target genes by western 
blot or real-time PCR (e.g. NQO1, GCLC etc) could be useful. 
Based on ROFA neurotoxicity in human neuroblastoma cell culture, we found that 
pre-treatment with Sv provided a great protection. Our results suggest that for its efficacy in 
diminishing ROS production, Sv reduces apoptosis and senescence percentages thus, 
restoring viability levels.  
It has to be pointed out that the preventive effect of Sv does not depend on the 
cholesterol synthesis pathway given that the addition of mevalonate did not modify the 
outcome for any of the parameters measured in this study.  
In general, PM not only exerts imbalance of the oxidative metabolism but, 
inflammation as well. The onset of oxidative stress can cause altered cell signaling pathways 
which, may activate pro-inflammatory mediators (Donaldson et al., 2006). Particularly, 
associations between oxidative stress and inflammatory responses to particles have been 
widely described within the literature (Donaldson et al., 2005; Rahman and MacNee, 2000).  
In brief, we found that ROFA on SH-SY5Y cells were able to increase not only the 
generation of O2-, but raise Nrf2 nuclear translocation, apoptosis and senescence in a dose 
dependent manner while reduces cell viability. On the contrary, in ROFA exposed 
neuroblastoma cell cultures upon treatment with Sv cell viability values were restored to 
basal level. In accordance, Sv pretreatment induced a reduction in positive staining 
percentage of apoptotic (Caspase-3 and PARP) as well as senescence biomarkers (SA- β-
gal). 
Therefore, we conclude that using an in vitro exposure system; pretreatment with 
simvastatin may provide neuroprotection against Residual Oil Fly Ash (air particulate matter) 
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Legend to the figures 
 
Figure 1. Preventive effect of simvastatin (Sv) on ROFA exposed SH-SY5Y cell culture. 
SHSY-5Y cells not pretreated, pretreated with Sv or pretreated with both Sv and mevalonate 
(Mv) were exposed to increasing doses of ROFA and evaluated for cell viability with the MTT 
test. The table depicts results shown in the graph. * = p <0.001 vs Control; # = p < 0.001 vs 
corresponding non-pretreated group. 
Figure 2. Effects of simvastatin (Sv) on ROFA induced oxidative stress. A) Microphotograph 
of reactive (left panel, ROFA50) and non-reactive (right panel, Control) SH-SY5Y cells after 
NBT test (Magnification 1000x). B) SHSY-5Y cells not pretreated or pretreated with Sv were 
exposed to increasing doses of ROFA and evaluated for superoxide anion generation with 
the NBT test. * = p < 0.001 vs Control; # = p < 0.001 vs corresponding non-pretreated group. 
Figure 3. Effects of simvastatin (Sv) on SH-SY5Y cells’ antioxidant defense system induction. 
A) Microphotograph of Nrf2 immunocytochemical detection on control SH-SY5Y cells 
(negative, left panel) or Sv-pretreated cells (positive, right panel) (Magnification 1000x). B) 
SH-SY5Y cells not pretreated or pretreated with Sv were exposed to increasing doses of 
ROFA and evaluated immunocytochemically for Nrf2 induction. * = p < 0.001 vs Control; # = 
p < 0.001 vs corresponding non-pretreated group. 
Figure 4. Effects of simvastatin (Sv) on ROFA-induced apoptosis. SH-SY5Y cells not 
pretreated or pretreated with Sv were exposed to increasing doses of ROFA and evaluated 
immunocytochemically for apoptosis. A) immunocytochemical detection of Caspase-3 active 
cleaved fragment. B) immunocytochemical detection of PARP cleaved fragment. * = p < 
0.001 vs Control; # = p < 0.001 vs corresponding non-pretreated group. 
Figure 5. Effects of simvastatin (Sv) on ROFA-induced cell senescence. A) Microphotograph 
of reactive (left panel, ROFA50) and non-reactive (right panel, Control) SH-SY5Y cells after β-
Gal activity test (Magnification 1000x). B) SH-SY5Y cells not pretreated or pretreated with Sv 
were exposed to increasing doses of ROFA and evaluated for cell senescence induction. * = 












































ROFA 5 0,775±0,038 
ROFA 10 0,552±0,055* 
ROFA 50 0,520±0,045* 
Sv+ROFA 5 0,872±0,024 
Sv+ROFA 10 0,835±0,023# 
Sv+ROFA 50 0,770±0,074# 
Sv+Mv+ROFA 5 0,717±0,033 
Sv+Mv+ROFA 10 0,724±0,031# 
Sv+Mv+ROFA 50 0,715±0,036# 
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